BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 15868597)

  • 1. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical intestinal transplantation: a decade of experience at a single center.
    Abu-Elmagd K; Reyes J; Bond G; Mazariegos G; Wu T; Murase N; Sindhi R; Martin D; Colangelo J; Zak M; Janson D; Ezzelarab M; Dvorchik I; Parizhskaya M; Deutsch M; Demetris A; Fung J; Starzl TE
    Ann Surg; 2001 Sep; 234(3):404-16; discussion 416-7. PubMed ID: 11524593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical intestinal transplantation: new perspectives and immunologic considerations.
    Abu-Elmagd K; Reyes J; Todo S; Rao A; Lee R; Irish W; Furukawa H; Bueno J; McMichael J; Fawzy AT; Murase N; Demetris J; Rakela J; Fung JJ; Starzl TE
    J Am Coll Surg; 1998 May; 186(5):512-25; discussion 525-7. PubMed ID: 9583691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
    Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small bowel transplant: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2003; 3(1):1-72. PubMed ID: 23074441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of intestinal transplantation in children.
    Reyes J; Bueno J; Kocoshis S; Green M; Abu-Elmagd K; Furukawa H; Barksdale EM; Strom S; Fung JJ; Todo S; Irish W; Starzl TE
    J Pediatr Surg; 1998 Feb; 33(2):243-54. PubMed ID: 9498395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of intestinal transplant recipients receiving maintenance basiliximab, sublingual tacrolimus and prednisone: A case series.
    Di Cocco P; Martinino A; Bencini G; Christensen R; Valdepenas B; Petrochenkov E; Akshelyan S; Almario-Alvarez J; Spaggiari M; Tzvetanov I; Benedetti E
    Hum Immunol; 2024 May; 85(3):110787. PubMed ID: 38480040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of hepatic transplantation at the University of Pittsburgh.
    Abu-Elmagd K; Fung J; Todo S; Rao A; Reyes J; Demetris J; Mazariegos G; Fontes P; McMichael J; Furukawa H
    Clin Transpl; 1995; ():145-70. PubMed ID: 8794262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression Protocols in Intestinal and Multivisceral Transplantation-A Literature Review.
    Ferreira MA; Ouverney LFF; Figueiredo MC; David AI
    Transplant Proc; 2023; 55(6):1431-1436. PubMed ID: 37088617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid elimination-who, when, how?
    Matas AJ
    Transplant Proc; 2008 Dec; 40(10 Suppl):S52-6. PubMed ID: 19100910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic immunosuppression for organ transplantation.
    Starzl TE; Murase N; Abu-Elmagd K; Gray EA; Shapiro R; Eghtesad B; Corry RJ; Jordan ML; Fontes P; Gayowski T; Bond G; Scantlebury VP; Potdar S; Randhawa P; Wu T; Zeevi A; Nalesnik MA; Woodward J; Marcos A; Trucco M; Demetris AJ; Fung JJ
    Lancet; 2003 May; 361(9368):1502-10. PubMed ID: 12737859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 in pediatric kidney transplantation--primary and rescue experience.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Tzakis AG; Ellis D; Gilboa N; Hopp L; McCauley J; Irish W
    Pediatr Nephrol; 1995; 9 Suppl(Suppl):S43-8. PubMed ID: 7492486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement.
    Trezeguet Renatti G; Riva N; Minetto J; Reijenstein H; Gole M; Meza V; Bosaleh A; Licciardone N; Aredes D; Lauferman L; Cervio G; Dip M; Schaiquevich P; Halac E; Imventarza O
    Liver Transpl; 2024 Jan; 30(1):61-71. PubMed ID: 37439661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in induction immunosuppression regimens for intestinal transplantation.
    Paulo Guzman J; Maklad M; Osman M; Elsherif A; Fujiki M
    Hum Immunol; 2024 May; 85(3):110800. PubMed ID: 38599892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Transplantation: Include the Spleen with Intestinal Graft?
    Matsumoto R; Kato T
    Gastroenterol Clin North Am; 2024 Jun; 53(2):281-288. PubMed ID: 38719378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric intestine and multivisceral transplant.
    Maklad M; Mazariegos G; Ganoza A
    Curr Opin Organ Transplant; 2023 Aug; 28(4):316-325. PubMed ID: 37418582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal multivisceral transplantation.
    Todo S; Tzakis A; Abu-Elmagd K; Reyes J; Furukawa H; Nour B; Fung J; Demetris A; Starzl TE
    Transplantation; 1995 Jan; 59(2):234-40. PubMed ID: 7530873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion to tacrolimus alone compared to full immunosuppression following cardiac transplantation (TACTFUL).
    Pearston AP; Ingemi AI; Shaeffer ZA; Cameron CM; Biagi KT; Gobble M; Yehya A; Baran DA
    Clin Transplant; 2023 Dec; 37(12):e15140. PubMed ID: 37733704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
    Feng S; Bucuvalas JC; Mazariegos GV; Magee JC; Sanchez-Fueyo A; Spain KM; Lesniak A; Kanaparthi S; Perito E; Venkat VL; Burrell BE; Alonso EM; Bridges ND; Doo E; Gupta NA; Himes RW; Ikle D; Jackson AM; Lobritto SJ; Jose Lozano J; Martinez M; Ng VL; Rand EB; Sherker AH; Sundaram SS; Turmelle YP; Wood-Trageser M; Demetris AJ
    Hepatology; 2021 May; 73(5):1985-2004. PubMed ID: 32786149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol.
    Hartje-Dunn C; Blume ED; Bastardi H; Daly KP; Fynn-Thompson F; Gauvreau K; Singh TP
    Transplantation; 2024 Jan; 108(1):e8-e14. PubMed ID: 37788365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.